Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.
about
Emerging mass spectrometry-based approaches to probe protein-receptor interactions: focus on overcoming physiological barriersIdentification of reduction-susceptible disulfide bonds in transferrin by differential alkylation using O(16)/O(18) labeled iodoacetic acid.Evaluation of Nonferrous Metals as Potential In Vivo Tracers of Transferrin-Based Therapeutics.An 18O-labeling assisted LC/MS method for assignment of aspartyl/isoaspartyl products from Asn deamidation and Asp isomerization in proteinsA new liquid chromatography-mass spectrometry-based method to quantitate exogenous recombinant transferrin in cerebrospinal fluid: a potential approach for pharmacokinetic studies of transferrin-based therapeutics in the central nervous systems.
P2860
Mass spectrometry-guided optimization and characterization of a biologically active transferrin-lysozyme model drug conjugate.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Mass spectrometry-guided optim ...... lysozyme model drug conjugate.
@en
type
label
Mass spectrometry-guided optim ...... lysozyme model drug conjugate.
@en
prefLabel
Mass spectrometry-guided optim ...... lysozyme model drug conjugate.
@en
P2093
P2860
P356
P1476
Mass spectrometry-guided optim ...... lysozyme model drug conjugate.
@en
P2093
Cedric E Bobst
Igor A Kaltashov
Son N Nguyen
P2860
P304
P356
10.1021/MP400026Y
P407
P577
2013-04-10T00:00:00Z